- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01273740
Swedish External Support Study (SWEXSUS)
January 7, 2011 updated by: University Hospital, Linkoeping
Swedish External Support Study is Randomized Trial of the Effect of External Support of PTFE-grafts for Bypass to Below Knee Arteries.
Randomized study to evaluate the effect of adding external support to PTFE-grafts used for bypass to below knee arteries in patients with critical limb ischemia with respect to primary patency, secondary patency, and limb salvage.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
334
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
Critical limb ischemia Need for bypass surgery
Exclusion Criteria:
Can participate in follow-up Has suitable saphenous vein
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: External support
Bypass graft with external support
|
Bypass surgery with externally supported graft
|
|
Experimental: No external support
Bypass with graft without external support
|
Bypass surgery with externally supported graft
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
|---|
|
primary graft patency
|
Secondary Outcome Measures
Outcome Measure |
|---|
|
limb salvage
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Fredrik BG Lundgren, PhD, MD, Department of CardioVascular Surgery, University Hospital, Linköping, Sweden
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 1995
Primary Completion (Actual)
June 1, 1998
Study Completion (Actual)
June 1, 1998
Study Registration Dates
First Submitted
January 7, 2011
First Submitted That Met QC Criteria
January 7, 2011
First Posted (Estimate)
January 10, 2011
Study Record Updates
Last Update Posted (Estimate)
January 10, 2011
Last Update Submitted That Met QC Criteria
January 7, 2011
Last Verified
January 1, 2011
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- SWEXSUS
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Critical Limb Ischemia
-
R3 Vascular Inc.RecruitingCritical Limb Ischemia | Critical Lower Limb Ischemia | Critical Limb-Threatening IschemiaAustralia
-
Lithuanian University of Health SciencesRecruiting
-
Taiwan Bio Therapeutics Co., Ltd.Completed
-
Tissue GenesisU.S. Army Medical Research and Development CommandActive, not recruitingCritical Limb IschemiaUnited States
-
John Paul II Hospital, KrakowNational Center for Research and Development, Poland; KCRIActive, not recruiting
-
ReFlow Medical, Inc.Massachusetts General Hospital; Syntropic CorelabCompletedCritical Limb IschemiaDominican Republic
-
Reven Pharmaceuticals, Inc.ICON plc; ERT: Clinical Trial Technology SolutionsCompletedCritical Limb IschemiaUnited States
-
Assiut UniversityUnknown
-
Ottawa Hospital Research InstituteThe Ottawa HospitalCompletedCritical Limb IschemiaCanada
-
HemostemixSuspendedCritical Limb IschemiaCanada
Clinical Trials on External support
-
Noctem, LLCUnited States Department of Defense; Naval Health Research Center; US Air Force... and other collaboratorsActive, not recruitingChronic Insomnia | Implementation; Digital HealthUnited States
-
University Hospital PilsenEnrolling by invitationHeart Attack, RevascularizationCzechia
-
Vascular Graft Solutions Ltd.Completed
-
Kips Bay Medical, Inc.University Hospital, Basel, SwitzerlandTerminatedMyocardial Ischemia | Heart Diseases | Cardiovascular Diseases | Vascular Diseases | Coronary Artery Disease | Coronary Disease | Arteriosclerosis | Arterial Occlusive DiseasesSwitzerland
-
Vascular Graft Solutions Ltd.CompletedCoronary Artery DiseaseGermany, Austria, United Kingdom, Israel
-
Kips Bay Medical, Inc.University Hospital Schleswig-HolsteinTerminatedMyocardial Ischemia | Heart Diseases | Cardiovascular Diseases | Vascular Diseases | Coronary Artery Disease | Coronary Disease | Arteriosclerosis | Arterial Occlusive DiseasesGermany
-
Umeå UniversityThe Swedish Diabetes Foundation; The County Council of VästerbottenUnknown
-
University of FloridaPatient-Centered Outcomes Research Institute; National Cancer Institute (NCI)Not yet recruitingHuman Papillomavirus (HPV) VaccinesUnited States
-
VA Office of Research and DevelopmentUniversity of California, Los Angeles; RANDCompletedPatient-centered Medical Home ImplementationUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingAnn Arbor Stage I Grade 1 Follicular Lymphoma | Ann Arbor Stage I Grade 2 Follicular Lymphoma | Ann Arbor Stage II Grade 1 Follicular Lymphoma | Ann Arbor Stage II Grade 2 Follicular Lymphoma | Ann Arbor Stage IV B-Cell Non-Hodgkin Lymphoma | Ann Arbor Stage I B-Cell Non-Hodgkin Lymphoma | Ann... and other conditionsUnited States